Clinical Trial Update: A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH) [Phase 3]

View source ↗

Summary

This clinical trial update reports results from a 1-year study assessing long-term exposure to eptinezumab in adults with chronic cluster headache. The study ai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cluster Headache

Drugs mentioned

• VYEPTI (eptinezumab)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Chronic Cluster Headache | Phase 3 | Status: COMPLETED | Results posted: 2024-08-06